#clinical - Techseriesinsight

May 16, 2025
PRNewswire
Biotechnology

Genome & Company’s Skincare Brand UIQ Expands into North America with Official Amazon Brand Store Launch

Genome & Company, a global clinical-stage biotechnology firm, has officially launched its skincare brand UIQ (www.theuiq.com) on Amazon, the largest e-commerce platform in the United States. UIQ, renowned for its...

May 16, 2025
PRNewswire
Cloud

Haier Consolidates Its Position as One of the Most Valuable Global Brands and the Only IoT Ecosystem Brand in the World USA – English

Haier Group proudly announces that it has been ranked 54th in the 2025 Kantar BrandZ Top 100 Most Valuable Global Brands, with a brand value of USD 47.6 billion, marking an...

May 15, 2025
PRNewswire
Biotechnology

Dizal to Present Promising Clinical Data on Golidocitinib and DZD8586 for the Treatment of Lymphoma at the Coming International Hematology Conferences

Dizal (SSE:688192), a biopharmaceutical company committed to developing novel medicines for the treatment of cancer and immunological diseases, announced that the latest data from eight hematologic malignancy clinical trials...

May 14, 2025
PRNewswire
Biotechnology

Aethlon Medical Announces Publication of Preclinical Data Showing Ability of the Hemopurifier® to Remove Platelet-Derived Extracellular Vesicles from Plasma

Aethlon Medical, Inc. (Nasdaq: AEMD), a medical therapeutic company focused on developing products to treat cancer and life-threatening infectious diseases, today announced the publication (https://www.biorxiv.org/cgi/content/short/2025.05.09.652772v1) of a pre-clinical ex vivo study...

May 9, 2025
PRNewswire
Healthcare

SystImmune, Inc. to Present Updated izalontamab brengitecan (iza-bren) Data in Locally Advanced or Metastatic Breast Cancer at ESMO Breast 2025

SystImmune, Inc. (SystImmune), a clinical-stage biotechnology company, today announced that one abstract on izalontamab brengitecan (iza-bren), a potentially first-in-class EGFRxHER3 bispecific antibody drug conjugate (ADC) will be presented at the...

May 8, 2025
PRNewswire
Blockchain Technology

SurgiBox Inc. Secures US Patent for Revolutionary Medical Blockchain Technology for Artificial Intelligence Applications

SurgiBox Inc., a pioneer in healthcare innovation, today announced it has secured a new US patent for its groundbreaking blockchain-based data management system designed to revolutionize medical procedure data security and...

May 8, 2025
PRNewswire
Biotechnology

REGENXBIO Announces Presentations at the American Society of Gene & Cell Therapy 28th Annual Meeting

REGENXBIO Inc. (Nasdaq: RGNX) today announced presentations at the American Society of Gene & Cell Therapy (ASGCT) 28th Annual Meeting, taking place in New Orleans, May 13 through 17, 2025. The presentations...

May 8, 2025
PRNewswire
Biotechnology

TransCode Therapeutics Successfully Completes Initial Dosing of Patients in Cohort 4 of Phase 1a Clinical Trial; No Dose Limiting Toxicities Reported

TransCode Therapeutics, Inc. (NASDAQ: RNAZ), the RNA oncology company committed to more effectively treating cancer using RNA therapeutics, today announced that the third patient in Cohort 4 of its Phase...

May 7, 2025
PRNewswire
Healthcare

Citizen Health Partner to Support Drug Development and Long-Term Patient Outcomes in PKP2 Cardiomyopathy

Citizen Health today announced a strategic partnership to support Rocket Pharmaceutical Inc.’s (Rocket Pharma) clinical and long-term data initiatives for arrhythmogenic cardiomyopathy (ACM) caused by mutations in the PKP2 gene. PKP2-ACM...

May 1, 2025
PRNewswire
Biotechnology

Sapience Therapeutics Announces Oral Presentation at the Upcoming 2025 American Society of Clinical Oncology (ASCO) Annual Meeting Featuring Lucicebtide Phase 2 Results

Sapience Therapeutics, Inc., a clinical-stage biotechnology company focused on the discovery and development of peptide therapeutics to address oncogenic and immune dysregulation that drive cancer, today announced that data from...